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In April 2009, we marked the five year
anniversary of PLoS Medicine’s first call for
papers with an editorial titled ‘‘A Medical
Journal for the World’s Health Priorities’’
[1]. The editorial was a renewed and
revitalized call for papers, announcing a
‘‘refocusing of the journal’s priorities.’’
Going forward, we said, we would prior-
itize papers addressing those diseases with
the greatest global burden. We would also
aim to be as broad a journal as possible,
publishing papers that explored not just
biological causes of illness, but also social,
environmental, and political determinants
of health. Six months later, as we now
mark the journal’s official five-year anni-
versary (our launch issue was October 19,
2004), has our refocused scope had any
impact on what we publish?
Gro Harlem Brundtland, former direc-
tor general of the World Health Organi-
zation, has argued that health problems
are ‘‘no longer just local, national or
regional, they are global’’ [2]. Events over
the past six months support this view, and
have reaffirmed to us that our new
direction — unreservedly global and
inclusive of politics, society, and the
environment — makes sense. Pandemic
H1N1 influenza (‘‘swine flu’’) was identi-
fied in April 2009 and has spread rapidly
across the globe. In May 2009, the global
health impact of climate change moved
higher up the international agenda
through the launch of an innovative
multidisciplinary report by University
College London and The Lancet, called
‘‘Managing the Health Effects of Climate
Change’’ [3]. Throughout the summer,
violent political conflicts flared up in many
of the world’s hotspots for war, such as Sri
Lanka, Afghanistan, and the Democratic
Republic of the Congo, causing major
morbidity and mortality. These events
illustrate how ‘‘human health remains
inextricably intertwined with the environ-
ment — in its widest sense — in which we
live,’’ as we wrote in our April 2009
editorial [1].
Authors have clearly taken notice of our
refocused scope. We are now seeing an
increasing number of cover letters that
state that the accompanying submission is
a response to our recent call for papers.
Our new direction is also reflected in the
papers that we have published in the last
six months. Our focus on the global
burden of disease can be seen in an
international study, based on mental
health surveys worldwide, examining the
link between mental disorders and suicide
[4]; in two systematic reviews that helped
to answer important questions about drug
treatment for tuberculosis [5,6]; and in a
randomized controlled trial of solar drink-
ing water disinfection that showed it not to
reduce childhood diarrhea despite wide-
spread promotion of the intervention [7].
Our focus on the interconnectedness
between health and the broader contexts
(ecological, social, and political) is seen in a
study of the impact of demographic
transition on dengue [8]; in essays on the
link between home foreclosures (reposses-
sions) and public health [9] and on the
health impact of Somalia’s civil war [10];
and in our recently launched series on
treating mental health problems in low-
and middle-income countries [11].
We will, of course, continue to publish
important laboratory and clinical studies
that have clear implications for clinical
medicine or public health. Examples of
such studies from the last six months
include the discovery and characterization
of a new tumor suppressor gene, ductal
epithelium–associated RING Chromosome 1
(DEAR1) [12]; a cohort study showing that
preconceptional folate supplementation is
associated with a 50%–70% reduction in
the incidence of early spontaneous pre-
term birth [13]; and a study on the
preclinical natural history of serous ovar-
ian cancer [14].
In addition to PLoS Medicine taking a
new direction, PLoS spent the spring and
summer engaged in four new projects and
initiatives that highlight some of our
underlying values, ideals, and commit-
ments. First, PLoS Medicine is deeply
committed to promoting transparency in
medical research, which is why the
journal, represented by the public interest
law firm Public Justice (http://www.tlpj.
org), intervened in an ongoing court case
in which women were suing Wyeth, the
manufacturers of Prempro, a hormone
replacement therapy [15]. We intervened
in the case in order to unseal a massive
amount of documentary evidence showing
a coordinated campaign of ghostwriting
from Wyeth on articles about this drug
and other hormone replacement therapies.
Our intervention was successful, and on
August 21, 2009 we created the ‘‘Wyeth
Ghostwriting Archive,’’ which makes
about 1,500 relevant documents publicly
available [16].
Second, PLoS is continually working to
refine and improve the communication of
health and science research. The 2009
H1N1 influenza pandemic highlights the
need for a new way for scientists to rapidly
exchange data, and on August 20, 2009
PLoS responded by launching an experi-
mental online platform called PLoS Cur-
rents: Influenza [17]. Submissions are as-
sessed by an expert group of influenza
researchers, but in the interest of timeli-
ness they do not undergo in-depth peer
review. Published articles are also depos-
ited into a new independent research
database run by the National Institutes of
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A key component of the PLoS Currents:
Influenza platform is a Google project
called Google Knol, which allows com-
munity interaction, comment, and discus-
sion around ‘‘knols’’ or units of knowledge
[19]. Articles in PLoS Currents: Influenza will
generally report preliminary findings, and
authors are likely to develop their studies
further before formally submitting them to
a peer-reviewed journal (such as the PLoS
journals).
Third, we have long been working on
finding better ways to evaluate the impact
of research. The impact factor assigned to
a journal by Thomson Scientific is an
extremely poor — and highly unscientific
— measure of the worth of an individual
study [20]. In June 2006, a PLoS Medicine
editorial noted that ‘‘The opening up of
the literature means that better ways of
assessing papers and journals are coming
— and we should embrace them’’ [20].
On September 15, 2009, PLoS took a big
step toward better assessment by launch-
ing a set of metrics attached to every paper
published in every PLoS journal that tells
you, at a glance, what kind of impact a
paper has had. The metrics include online
usage data (page views and downloads),
citation counts, comments and ratings by
readers, social bookmarks, and blog cov-
erage. As far as we know, this is the first
attempt by a large publisher to publicly
provide such a broad range of transparent
usage data for each of its articles.
Finally, we believe that an important
advantage of open access publication is the
opportunity for engaging readers worldwide
in an ongoing conversation about health
and health research. On May 21, 2009
we launched a new venture aimed at such
engagement, the Speaking of Medicine com-
munity blog (http://speakingofmedicine.
plos.org/). Here you’ll find a diverse array
of blogs andpodcasts fromthePLoSMedicine
editors and publications staff, members of
the journal’s editorial board, medical stu-
dents, and invited ‘‘guest contributors.’’
Encouraged by reader comments, we have
been posting new entries at an accelerating
rate, and we now include regular features
such as the ‘‘Daily Click’’ (a ‘‘pick of the
day’’ from a member of the PLoS Medicine
team, highlighting a particularly compelling
item on the web) and links to relevant
videos, pubcasts, and the PLoS Twitter feed
(http://twitter.com/PLOS). We invite you
to join the conversation.
In a 2005 article in the Medical Journal of
Australia, Richard Smith, former editor of
the BMJ and a current member of the
PLoS Board of Directors, posed the
question: ‘‘Can medical journals lead or
must they follow?’’ [21]. He concluded
that the main contribution of journals
‘‘may be less to try and achieve precise
reform and more to put issues firmly on
the agenda.’’ In our first five years, PLoS
Medicine tried to show such leadership by
demonstrating why open access matters to
medicine, by working to break the cycle of
dependency between medical journals and
the marketing programs of drug compa-
nies, by raising standards of research
reporting, and by making the case that a
modern medical journal should look
outward—beyond biology—and respond
to the needs of a wider, global society. We
look forward to engaging with whatever
the next five years bring.
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